China's first COVID-19 antibody drug cuts hospitalizations, deaths 80%

BEIJING: China’s first home-developed anti-COVID-19 drug-using antibody cocktail therapy has been approved for marketing, after being found

Related Keywords

Philippines ,Mexico ,Argentina ,Shenzhen ,Guangdong ,China ,Brazil ,Inner Mongolia ,Nei Mongol ,Beijing ,South Africa ,Jilin ,Zhang Linqi ,Brii Biosciences ,National Medical Products Administration ,Tsinghua University ,Tsinghua University School Of Medicine ,Global Times ,Third People ,Drug Administration ,